Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 – 2018 Sep 26th 2013, 00:00, by swapnil Cancer/Tumor profiling is a promising market and is witnessing significant growth in the healthcare industry. It is poised to grow rapidly in a range of application areas, including biomarker discovery and prognosis. The global cancer/tumor profiling market is valued at $14.99 billion in 2013 and is expected to reach $35.03 billion by 2018. A list of tests (for example, Barium X-ray, Blood tests, Bone marrow, Cystoscopy, Lumbar puncture) is available, used for diagnosing specific types of cancer. Also, there are different treatment options for cancer, including chemotherapy, hormone therapy, surgery, radiotherapy, bisphosphonates, bone marrow and stem cell transplants, and biological …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=117219.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/cancertumor-profiling-market-applications-personalized-medicine-diagnostics-biomarker-discovery-prognosis-research-technologies-ngs-qpcr-ihc-fishcish-microarray-segments-genomics-pr-market-report.html. |
No comments:
Post a Comment